Cost-effectiveness of fondaparinux vs enoxaparin as prophylaxis against venous thromboembolism following orthopaedic surgery

被引：1
|
作者：
Posnett, J [1 ]
Gordois, A [1 ]
机构：
[1] Univ York, York YO10 5DD, N Yorkshire, England
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61196-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：444 / 444
页数：1
相关论文
共 50 条
  • [21] Fondaparinux is cost-effective compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing surgery for hip replacement.
    Sullivan, SD
    Kahn, SR
    Muntz, JE
    [J]. PHARMACOTHERAPY, 2003, 23 (10): : 1355 - 1355
  • [22] Venous thromboembolism prophylaxis with rivaroxaban subsequent to enoxaparin in major orthopaedic surgery
    Altintas, F.
    Ulucay, C.
    Ozler, T.
    Kilincoglu, V
    Guzelbey, T.
    Aksu, B. C.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1115 - 1115
  • [23] Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium
    Annemans, L
    Minjoulat-Rey, MC
    De Knock, M
    Vranckx, K
    Czarka, M
    Gabriel, S
    Haentjens, P
    [J]. ACTA CLINICA BELGICA, 2004, 59 (06) : 346 - 357
  • [24] PROPHYLAXIS OF VENOUS THROMBOEMBOLISM - ANALYSIS OF COST-EFFECTIVENESS
    SALZMAN, EW
    DAVIES, GC
    [J]. ANNALS OF SURGERY, 1980, 191 (02) : 207 - 218
  • [25] Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery
    Lundkvist, Jonas
    Bergqvist, David
    Jonsson, Bengt
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (04): : 313 - 323
  • [26] Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery
    Jonas Lundkvist
    David Bergqvist
    Bengt Jönsson
    [J]. The European Journal of Health Economics, 2007, 8 : 313 - 323
  • [27] THE COST-EFFECTIVENESS OF ENOXAPARIN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING MAJOR SURGERY IN EGYPT
    Farag, A.
    Moety, Abdel H.
    Hassan, L.
    Pathak, P.
    Lamotte, M.
    Levorsen, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S895 - S895
  • [28] Postpartum venous thromboembolism prophylaxis: A Cost-Effectiveness Analysis
    Becker, David A.
    Einerson, Brett D.
    Wetta, Luisa L.
    Kuper, Spencer G.
    Casey, Brian M.
    Subramaniam, Akila
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S487 - S488
  • [29] Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery
    Gillespie, W
    Murray, D
    Gregg, PJ
    Warwick, D
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2000, 82B (04): : 475 - 479
  • [30] Prophylaxis of venous thromboembolism in orthopaedic surgery
    Abad, JI
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (5-6) : 403 - 405
12345